Antibody study for Lyme disease
Part of Brain & nervous system, Infections, Mouth & dental clinical trials.
This study looks for certain antibodies in people with Lyme disease to understand how the body responds to the infection. It may help improve diagnosis or treatment for Lyme disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Lyme disease based on standard European guidelines.
- You do not have an autoimmune disease (like lupus or rheumatoid arthritis).
- You have not recently had a heart attack or a blood clot in your leg or lungs.
- You are not pregnant.
- You do not have syphilis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood antibody test results in adults who may have tick-borne encephalitis and also signs of Lyme disease. It may help researchers understand how these infections relate and which lab patterns fit different illnesses.
This study enrolls people diagnosed with early Lyme disease (erythema migrans) to learn how people’s expectations about symptoms may affect what happens after treatment. Your experience and beliefs will be compared to see if they relate to post-Lyme symptoms.
This trial tests if a probiotic (Saccharomyces boulardii) can help maintain healthy gut bacteria while you take antibiotics for the early skin rash of Lyme disease (erythema migrans). You'll take amoxicillin for 14 days, plus either the probiotic or a placebo.
This trial is testing a new blood test to help diagnose Lyme disease (borrelia infection) in children. If you are at the emergency room with symptoms that might be Lyme disease and you have a healthy immune system, you might be able to join.
This study looks at how the immune system reacts to the bacteria that cause Lyme disease in people with a skin condition called ACA. It may help doctors understand the disease better and guide future treatments.
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
Hear when a new Blood Donors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.